Liraglutide attenuates type 2 diabetes mellitus-associated non-alcoholic fatty liver disease by acti...
Liraglutide attenuates type 2 diabetes mellitus-associated non-alcoholic fatty liver disease by activating AMPK/ACC signaling and inhibiting ferroptosis
About this item
Full title
Author / Creator
Guo, Tingli , Yan, Wenhui , Cui, Xin , Liu, Na , Wei, Xiaotong , Sun, Yuzhuo , Fan, KeXin , Liu, Jieyun , Zhu, Yuanyuan , Wang, Zhuanzhuan , Zhang, Yilei and Chen, Lina
Publisher
London: Springer
Journal title
Language
English
Formats
Publication information
Publisher
London: Springer
Subjects
More information
Scope and Contents
Contents
Background Non-alcoholic fatty liver disease (NAFLD) is one of the most common complications of type 2 diabetes mellitus (T2DM). The pathogenesis of NAFLD involves multiple biological changes, including insulin resistance, oxidative stress, inflammation, as well as genetic and environmental factors. Liraglutide has been used to control blood sugar....
Alternative Titles
Full title
Liraglutide attenuates type 2 diabetes mellitus-associated non-alcoholic fatty liver disease by activating AMPK/ACC signaling and inhibiting ferroptosis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_2535d181d9854339ac5dfd3b41529ddd
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2535d181d9854339ac5dfd3b41529ddd
Other Identifiers
ISSN
1528-3658,1076-1551
E-ISSN
1528-3658
DOI
10.1186/s10020-023-00721-7
